|
Please join NACDL on Tuesday, Dec. 17th from 3:30-5:00pm ET / 12:30-2:00pm PT for an important webinar on the impact of opioid use on the brain.
|
|
With more than 50% of individuals in our nation's jails and prisons having a substance use history, it is critical that the defense community as well as all other legal system professionals understand the ways in which substance use impacts the brain. Dr. Amy Fitzpatrick, a board-certified addiction medicine specialist, will share how opioids impact key brain functions like memory and decision-making, as well as information on how this impacts a person's experience within the legal system.
Details
- Date: Tuesday, December 17
- Time: 3:30-5:00pm ET / 12:30-2:00pm PT
- Presenter: Dr. Amy Fitzpatrick, Boston Medical Center
- Cost: Free, but registration is required
- Audience: This program is open to all
Note: No CLE credit is being offered for this program.
This FREE webinar is sponsored by RTI International and supported by a grant from the Bureau of Justice Assistance (BJA) as a part of DOJ's Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP).
|
|
BJA's COSSUP is a collaborative effort that includes the training and technical assistance teams from Abt Global; Altarum; the Center for Health and Justice at Treatment Alternatives for Safe Communities; the Institute for Intergovernmental Research; the National Criminal Justice Training Center of Fox Valley Technical College; the Prescription Drug Monitoring Program Training and Technical Assistance Center; RTI International; and Rulo Strategies.
This project was supported by Grant No. 15PBJA-21-GK-01074-MUMU awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice's Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office for Victims of Crime, and the Office of Sex Offender Sentencing, Monitoring, Apprehending, Registering, and Tracking (SMART). Points of view or opinions are those of the presenters and do not necessarily represent the official position or policies of the U.S. Department of Justice.
|
Presenter
Amy Fitzpatrick, MD, is board-certified in both internal medicine and addiction medicine. She works in the outpatient Office Based Addiction Treatment (OBAT) clinic at Boston Medical Center and attends on the inpatient Addiction Consult Service (ACS).
Dr. Fitzpatrick does clinical research in the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center with a focus on providing training and technical assistance to community hospitals who are initiating opioid use disorder treatment in their inpatient settings. In addition to her duties at Boston University School of Medicine and Boston Medical Center, She serves as an expert consultant for the Massachusetts Consultation Service for the Treatment of Addiction and Pain (MCSTAP) which supports Massachusetts clinicians in increasing their capacity for, and comfort in, using evidence based practices in screening for, diagnosing, treatment and managing the care of patients with substance use disorders, chronic pain, or both. MCSTAP provides real-time telephonic consulation on safe prescri bing and managing care for these patients.
She also works as the Medical Director/Chief Medical Officer for Ark Behavioral Health which has several Massachusetts facilities that offer detox, residential, partial hospitalization, and intensive outpatient treatments for substance use disorders.
Dr. Fitzpatrick is an Assistant Professor of Medicine at Chobanian & Avedisian School of Medicine, a primary care physician in the Women's Health Group in the section of General Internal Medicine at Boston Medical Center, and the co-director of the Belkin Breast Clinic.
|
|
|
|
|
|
|
